comparemela.com

Latest Breaking News On - Fennec pharmaceuticals inc - Page 8 : comparemela.com

Fennec Announces Incremental $5 Million Investment from Petrichor

~ Supports Strategic Discussions and Global Launch Activities ~ ~ Extends Access to Additional Undrawn Capital As Needed During Global PEDMARKĀ® Rollout ~ ~ Facilitates Market Expansion.

Oregon
United-states
Michael-beecham
Lindsay-rocco
Rosty-raykov
Landierw-ototoxicity
Robert-andrade
Elixir-health-public-relations
Clinical-oncology-group
Science-university
Fennec-pharmaceuticals-inc
Nasdaq

Fennec Pharmaceuticals Inc. (TSE:FRX) Director Khalid Islam Acquires 20,492 Shares

Fennec Pharmaceuticals Inc. (TSE:FRX – Get Free Report) Director Khalid Islam purchased 20,492 shares of Fennec Pharmaceuticals stock in a transaction that occurred on Thursday, November 16th. The shares were bought at an average cost of C$2.44 per share, for a total transaction of C$50,000.48. Fennec Pharmaceuticals Stock Up 2.5 % Shares of TSE:FRX opened […]

Khalid-islam
Fennec-pharmaceuticals-stock
Fennec-pharmaceuticals-inc
News-ratings-for-fennec-pharmaceuticals-daily
Fennec-pharmaceuticals
Get-free-report
Director-khalid-islam
Pharmaceuticals-inc
Fennec-pharmaceuticals-daily
Tse-frx
Frx
Medical

Fennec Pharmaceuticals to Participate in Upcoming Investor

RESEARCH TRIANGLE PARK, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty.

New-york
United-states
United-kingdom
London
City-of
Oregon
Lindsay-rocco
Robert-andrade
Craig-hallum-alpha
Drug-administration
Fennec-pharmaceuticals-inc
Elixir-health-public-relations

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals Third Quarter 2023 Earnings and Corporate Update Conference Call.

France
Dublin
Ireland
United-kingdom
Italy
Spain
London
City-of
United-states
Germany
German
Robert-andrade

Fennec Pharmaceuticals (NASDAQ:FENC) Announces Earnings Results, Beats Expectations By $0.04 EPS

Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report) released its earnings results on Monday. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.04, MarketWatch Earnings reports. The firm had revenue of $6.52 million during the quarter, compared to the consensus estimate of $5.22 million. During the same […]

United-states
California
Canada
America
Fennec-pharmaceuticals-company-profile
Earnings-history-for-fennec-pharmaceuticals
News-ratings-for-fennec-pharmaceuticals-daily
Royal-bank
Fennec-pharmaceuticals
Fennec-pharmaceuticals-price-performance
Hedge-funds-weigh-in-on-fennec-pharmaceuticals

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.